SMC advice on the use of bortezomib subcutaneous injection

SMC advice on the use of subcutaneous bortezomib injection within NHS Scotland in combination with melphalan and prednisone for the treatment of previously untreated non-transplant eligible myeloma patient or for the treatment of relapsed myeloma patients who have received at least one prior treatment and who have already undergone or are not transplant eligible.

An Introduction

This leaflet is written for AL amyloidosis patients. It aims to:

  • Provide a brief overview of AL amyloidosis and its treatment
  • Answer some of the more common questions about AL amyloidosis
  • Help patients make informed decisions about their treatment

NICE guidance on the use of opioids in palliative care

Best practice advice on the care of patients with advanced and progressive disease who require strong opioids for pain control. These patients are defined as those in severe pain who may be opioid-naive, or those whose pain has been inadequately controlled on step two of the WHO pain ladder.



European Organisation for Research and Treatment of Cancer (EORTC) assessment of quality of life of cancer patients involving a 30 item questionnaire.